Business Standard

Tuesday, December 24, 2024 | 05:57 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 cr

Image

Press Trust of India New Delhi

Drug firm AstraZeneca Pharma India Tuesday reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018.

The company had posted a net profit of Rs 27.38 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.

Company's total revenue for the quarter under consideration stood at Rs 164.71 crore. It was Rs 166.75 crore for the same period year ago.

Shares of AstraZeneca Pharma India today closed at Rs 1,702.60 per scrip on BSE, up 0.70 per cent from the previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 13 2018 | 9:10 PM IST

Explore News